Arkolith/Insider Trading/AKBA/Form 4

Rucci Carolyn M.

SVP, Chief Legal OfficerAkebia Therapeutics, Inc. (AKBA) · full profile →Form 4 · filed Feb 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$97K
Net Open-Market Flow
-$97K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Sell(S)17K$1.39$23K641K
Feb 2, 2026Sell(S)25K$1.39$35K616K
Feb 2, 2026Sell(S)28K$1.39$38K588K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002107264-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML